Member Info for moonparty

Well I am currently recovering from Omicron despite being triple jabbed and having had the original coronavirus.
Agree C11, would seem sensible if there are basically no candidates with no jabs or precious infections. The data they are looking for is immune response - so long as they can measure the change in this due to the vaccine, it will be good data.

Thanks WTP, for those who can't get past the paywall, same story here:
https://www.independent.ie/world-news/coronavirus/one-to-keep-an-eye-on-delta-omicron-hybrid-identified-for-first-time-41432194.html

News may well be due, and what a nice rise today.
However, Angle is being pushed on Facebook groups so could be a pump and dump. Take care everyone.

Oh, pdf is back now :)
https://haoma.com.au/wp-content/uploads/2022/03/Haoma-Mining-NL-Shareholder-Update-Pirra-Lithium-March-8-2022.pdf

The headline "Pirra Lithium - Significant Lithium Prospect Identified in East Pilbara". Nice!
But the linked pdf seems to have been pulled.
Some regulatory reason to do with Calidus being listed and trading halted?

Looking forward to Wednesday...

Love you guys with your conspiracy theories, but the truth is:
- delay in recruiting Covidity patients
- delay in FPD on Modi1
- general market sentiment with inflation numbers and Ukraine situation.

Not sure any of these were especially predictable or anything Scancell could have mitigated, so anyone claiming to have timed the market is deluded or lying.

Science and prospects all intact, still a strong buy for me.
No complex technical or political theories required.

Keras will need to raise funds at some point , if neither projects come good in the next few months.
Maybe longer, not exactly sure how long funds will last, and there may be some revenue from FI.
Anyway, my thought process is that if they do raise funds, it could be a positive - it will mean someone is prepared to bet that the situation is salvageable?
So, my plan is to wait for either a) positive news or b) fund raising, then possibly get on board. I will probably miss the lows, but happy to avoid the risk of neither project coming good.

Yes, if directors are privvy to price sensitive information (such as advanced pre negotiation for an offer / licencing deal) they shouldn't buy or sell shares. That would be insider dealing.

No conspiracy here as far as I can see.
Scancell are extremely busy, so have brought in somebody they know and trust to help them out in the short term.
Makes perfect sense. And good business sense.

I use II.
I originally held Keras shares, and II handled the Keras/Calidus split without any issue - at the time lots of other platforms seemed to be slow and/or required chasing.
I have bought more Calidus since, again without issue.

Different company now RR, you've got to let it go.
Apple was on it's knees before the market 'got' the iPhone.

US markets actually ended up on the day, after being heavily down at London close. Also, it's the last day to place your bets before the interims.

It also says last update Oct 14 2021, so clearly not up to date.
As their has been no information made public since the last update, I guess that's all they can say.

Definitely not finished - it doesn't matter that so many people have had it or had a vaccine. Like colds / flu, you have limited immunity against future mutations.
It is only chance that omicron was less deadly than delta, and only a matter of time before a variant pops up that is as transmissible as omicron and as deadly as delta.

The world does not yet have a solution.

Think it was intended as a metaphor for global warming tbh, but kinda works for CV too.
Happy New Year all.

Fun fact - next year is the first time we go backwards instead of forwards a year. It's twenty twenty too :)

What's more interesting to me is who bought the shares, not who sold.
There should be two TR1's issued shortly, assuming the 41M went to a single institution.
If the purchaser is a 'big pharma' , expect fireworks IMO.

I assume you mean this newsletter?
https://cepi.net/news_cepi/reflections-on-2021-from-cepi-ceo-dr-richard-hatchett/
It is an end of year summary, not an official news release, so there is no way they would mention news on collaborations or grants in such a piece.
Good luck with your upcoming purchase of Scancell shares kashdog.
Note - my opinion remains a 'strong buy'.

Machine learning has it's place and can be very powerful and there are some great applications in medicine, like predicting probabilities of serious illness from other symptoms.
It's pretty advanced machine learning to predict a virus mutation, and I would have thought computer modelling would be more suitable for this?
A long shot at best IMO.

https://theaseanpost.com/article/covid-mutates-vaccine-makers-are-adapting-too

Maybe if you are unhappy here, you should try a lower risk sector like biotech :)
But seriously, check out SCLP - a novel 2nd generation covid vaccine and cancer vaccines in trials now!